Once-a-week versus once-every-3-weeks Cisplatin chemoradiation for locally advanced head and neck cancer: A phase III randomized noninferiority trial
Key Publications on NACT and Targeted therapies in head and neck cancer
Chairpersons :
Alok Thakar, Krishnakumar Thankappan, K. S. Gopinath
Reviewer :
Vanita Norohna